Evaxion Biotech A/S

NASDAQ (USD): Evaxion Biotech A/S (EVAX)

Last Price

3.22

Today's Change

+0.82 (34.16%)

Day's Change

3.21 - 4.05

Trading Volume

58,727,935

Overview

Market Cap

1 Million

Shares Outstanding

6 Million

Avg Volume

1,259,102

Avg Price (50 Days)

5.20

Avg Price (200 Days)

12.97

PE Ratio

-0.23

EPS

-14.00

Earnings Announcement

25-Mar-2025

Previous Close

2.40

Open

3.88

Day's Range

3.21 - 4.05

Year Range

2.22 - 23.7

Trading Volume

58,752,494

Price Change Highlight

1 Day Change

35.00%

5 Day Change

29.08%

1 Month Change

-28.79%

3 Month Change

-75.46%

6 Month Change

-75.55%

Ytd Change

-29.87%

1 Year Change

-84.75%

3 Year Change

-97.89%

5 Year Change

-99.34%

10 Year Change

-99.34%

Max Change

-99.34%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. The company was incorporated in 2008 and is headquartered in Hørsholm, Denmark.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment